Global Molecular Residual Disease Detection Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
147
Industry
Medical Devices
Regions
Global
Updated
February 2026

Report Overview


Report Overview
Molecular residual lesions often refer to minimal residual lesions, which refer to a small number of cancer cells that remain in the body after cancer treatment (cancer cells that do not respond to treatment or are drug-resistant).

The global Molecular Residual Disease Detection market size was estimated at USD 6164.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 15.60% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Molecular Residual Disease Detection market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Molecular Residual Disease Detection market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Molecular Residual Disease Detection market.
Global Molecular Residual Disease Detection Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Adaptive
Guardant Health
Invitae
Cergentis B.V
LexentBio
Natera
BGI
Zhiben Medical
Burning Rock Medicine
Huidu Medical
Zhenhe Technology
ExactSciences

Market Segmentation (by Type)
Tumor-informed Assays
Tumor-agnostic Assays

Market Segmentation (by Application)
Prognosis
Adjuvant Treatment Decision-Making
Surveillance for Postoperative Recurrence
Other

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Residual Disease Detection Market
Overview of the regional outlook of the Molecular Residual Disease Detection Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Residual Disease Detection Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Molecular Residual Disease Detection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Molecular Residual Disease Detection
    • 1.2 Key Market Segments
      • 1.2.1 Molecular Residual Disease Detection Segment by Type
      • 1.2.2 Molecular Residual Disease Detection Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Molecular Residual Disease Detection Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Molecular Residual Disease Detection Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Molecular Residual Disease Detection Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Molecular Residual Disease Detection Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Molecular Residual Disease Detection Product Life Cycle
    • 3.3 Global Molecular Residual Disease Detection Sales by Manufacturers (2020-2025)
    • 3.4 Global Molecular Residual Disease Detection Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Molecular Residual Disease Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Molecular Residual Disease Detection Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Molecular Residual Disease Detection Market Competitive Situation and Trends
      • 3.8.1 Molecular Residual Disease Detection Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Molecular Residual Disease Detection Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Molecular Residual Disease Detection Industry Chain Analysis
    • 4.1 Molecular Residual Disease Detection Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Molecular Residual Disease Detection Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Molecular Residual Disease Detection Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Molecular Residual Disease Detection Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Molecular Residual Disease Detection Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Molecular Residual Disease Detection Sales Market Share by Type (2020-2025)
    • 6.3 Global Molecular Residual Disease Detection Market Size by Type (2020-2025)
    • 6.4 Global Molecular Residual Disease Detection Price by Type (2020-2025)
  • 7 Molecular Residual Disease Detection Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Molecular Residual Disease Detection Market Sales by Application (2020-2025)
    • 7.3 Global Molecular Residual Disease Detection Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Molecular Residual Disease Detection Sales Growth Rate by Application (2020-2025)
  • 8 Molecular Residual Disease Detection Market Sales by Region
    • 8.1 Global Molecular Residual Disease Detection Sales by Region
      • 8.1.1 Global Molecular Residual Disease Detection Sales by Region
      • 8.1.2 Global Molecular Residual Disease Detection Sales Market Share by Region
    • 8.2 Global Molecular Residual Disease Detection Market Size by Region
      • 8.2.1 Global Molecular Residual Disease Detection Market Size by Region
      • 8.2.2 Global Molecular Residual Disease Detection Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Molecular Residual Disease Detection Sales by Country
      • 8.3.2 North America Molecular Residual Disease Detection Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Molecular Residual Disease Detection Sales by Country
      • 8.4.2 Europe Molecular Residual Disease Detection Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Molecular Residual Disease Detection Sales by Region
      • 8.5.2 Asia Pacific Molecular Residual Disease Detection Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Molecular Residual Disease Detection Sales by Country
      • 8.6.2 South America Molecular Residual Disease Detection Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Molecular Residual Disease Detection Sales by Region
      • 8.7.2 Middle East and Africa Molecular Residual Disease Detection Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Molecular Residual Disease Detection Market Production by Region
    • 9.1 Global Production of Molecular Residual Disease Detection by Region(2020-2025)
    • 9.2 Global Molecular Residual Disease Detection Revenue Market Share by Region (2020-2025)
    • 9.3 Global Molecular Residual Disease Detection Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Molecular Residual Disease Detection Production
      • 9.4.1 North America Molecular Residual Disease Detection Production Growth Rate (2020-2025)
      • 9.4.2 North America Molecular Residual Disease Detection Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Molecular Residual Disease Detection Production
      • 9.5.1 Europe Molecular Residual Disease Detection Production Growth Rate (2020-2025)
      • 9.5.2 Europe Molecular Residual Disease Detection Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Molecular Residual Disease Detection Production (2020-2025)
      • 9.6.1 Japan Molecular Residual Disease Detection Production Growth Rate (2020-2025)
      • 9.6.2 Japan Molecular Residual Disease Detection Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Molecular Residual Disease Detection Production (2020-2025)
      • 9.7.1 China Molecular Residual Disease Detection Production Growth Rate (2020-2025)
      • 9.7.2 China Molecular Residual Disease Detection Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Adaptive
      • 10.1.1 Adaptive Basic Information
      • 10.1.2 Adaptive Molecular Residual Disease Detection Product Overview
      • 10.1.3 Adaptive Molecular Residual Disease Detection Product Market Performance
      • 10.1.4 Adaptive Business Overview
      • 10.1.5 Adaptive SWOT Analysis
      • 10.1.6 Adaptive Recent Developments
    • 10.2 Guardant Health
      • 10.2.1 Guardant Health Basic Information
      • 10.2.2 Guardant Health Molecular Residual Disease Detection Product Overview
      • 10.2.3 Guardant Health Molecular Residual Disease Detection Product Market Performance
      • 10.2.4 Guardant Health Business Overview
      • 10.2.5 Guardant Health SWOT Analysis
      • 10.2.6 Guardant Health Recent Developments
    • 10.3 Invitae
      • 10.3.1 Invitae Basic Information
      • 10.3.2 Invitae Molecular Residual Disease Detection Product Overview
      • 10.3.3 Invitae Molecular Residual Disease Detection Product Market Performance
      • 10.3.4 Invitae Business Overview
      • 10.3.5 Invitae SWOT Analysis
      • 10.3.6 Invitae Recent Developments
    • 10.4 Cergentis B.V
      • 10.4.1 Cergentis B.V Basic Information
      • 10.4.2 Cergentis B.V Molecular Residual Disease Detection Product Overview
      • 10.4.3 Cergentis B.V Molecular Residual Disease Detection Product Market Performance
      • 10.4.4 Cergentis B.V Business Overview
      • 10.4.5 Cergentis B.V Recent Developments
    • 10.5 LexentBio
      • 10.5.1 LexentBio Basic Information
      • 10.5.2 LexentBio Molecular Residual Disease Detection Product Overview
      • 10.5.3 LexentBio Molecular Residual Disease Detection Product Market Performance
      • 10.5.4 LexentBio Business Overview
      • 10.5.5 LexentBio Recent Developments
    • 10.6 Natera
      • 10.6.1 Natera Basic Information
      • 10.6.2 Natera Molecular Residual Disease Detection Product Overview
      • 10.6.3 Natera Molecular Residual Disease Detection Product Market Performance
      • 10.6.4 Natera Business Overview
      • 10.6.5 Natera Recent Developments
    • 10.7 BGI
      • 10.7.1 BGI Basic Information
      • 10.7.2 BGI Molecular Residual Disease Detection Product Overview
      • 10.7.3 BGI Molecular Residual Disease Detection Product Market Performance
      • 10.7.4 BGI Business Overview
      • 10.7.5 BGI Recent Developments
    • 10.8 Zhiben Medical
      • 10.8.1 Zhiben Medical Basic Information
      • 10.8.2 Zhiben Medical Molecular Residual Disease Detection Product Overview
      • 10.8.3 Zhiben Medical Molecular Residual Disease Detection Product Market Performance
      • 10.8.4 Zhiben Medical Business Overview
      • 10.8.5 Zhiben Medical Recent Developments
    • 10.9 Burning Rock Medicine
      • 10.9.1 Burning Rock Medicine Basic Information
      • 10.9.2 Burning Rock Medicine Molecular Residual Disease Detection Product Overview
      • 10.9.3 Burning Rock Medicine Molecular Residual Disease Detection Product Market Performance
      • 10.9.4 Burning Rock Medicine Business Overview
      • 10.9.5 Burning Rock Medicine Recent Developments
    • 10.10 Huidu Medical
      • 10.10.1 Huidu Medical Basic Information
      • 10.10.2 Huidu Medical Molecular Residual Disease Detection Product Overview
      • 10.10.3 Huidu Medical Molecular Residual Disease Detection Product Market Performance
      • 10.10.4 Huidu Medical Business Overview
      • 10.10.5 Huidu Medical Recent Developments
    • 10.11 Zhenhe Technology
      • 10.11.1 Zhenhe Technology Basic Information
      • 10.11.2 Zhenhe Technology Molecular Residual Disease Detection Product Overview
      • 10.11.3 Zhenhe Technology Molecular Residual Disease Detection Product Market Performance
      • 10.11.4 Zhenhe Technology Business Overview
      • 10.11.5 Zhenhe Technology Recent Developments
    • 10.12 ExactSciences
      • 10.12.1 ExactSciences Basic Information
      • 10.12.2 ExactSciences Molecular Residual Disease Detection Product Overview
      • 10.12.3 ExactSciences Molecular Residual Disease Detection Product Market Performance
      • 10.12.4 ExactSciences Business Overview
      • 10.12.5 ExactSciences Recent Developments
  • 11 Molecular Residual Disease Detection Market Forecast by Region
    • 11.1 Global Molecular Residual Disease Detection Market Size Forecast
    • 11.2 Global Molecular Residual Disease Detection Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Molecular Residual Disease Detection Market Size Forecast by Country
      • 11.2.3 Asia Pacific Molecular Residual Disease Detection Market Size Forecast by Region
      • 11.2.4 South America Molecular Residual Disease Detection Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Molecular Residual Disease Detection by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Molecular Residual Disease Detection Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Molecular Residual Disease Detection by Type (2026-2035)
      • 12.1.2 Global Molecular Residual Disease Detection Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Molecular Residual Disease Detection by Type (2026-2035)
    • 12.2 Global Molecular Residual Disease Detection Market Forecast by Application (2026-2035)
      • 12.2.1 Global Molecular Residual Disease Detection Sales (K Units) Forecast by Application
      • 12.2.2 Global Molecular Residual Disease Detection Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.